Buy Retatrutide Peptide (5mg, 10mg, 20mg, 30mg, 40mg) | The World’s Most Powerful Triple-Agonist for Metabolic Research

---

28.7%. In Eli Lilly’s landmark Phase 3 TRIUMPH-4 trial (December 2025), participants on the highest dose of Retatrutide lost an average of 28.7% of their body weight in just 68 weeks — that’s up to 71.2 lbs (32.3 kg) per person. No single or dual-agonist peptide has come remotely close. The global research community is paying very close attention. Are you?

Picture this: a researcher spends years grinding through data with single-pathway GLP-1 agonists, watching moderate results — then Retatrutide (LY3437943) enters the picture and rewrites the entire playbook. That’s not exaggeration. That’s exactly what’s happening in labs across the USA, Canada, Germany, France, and beyond right now.

Retatrutide for sale at Swiss Chems Official gives you access to this first-in-class triple hormone receptor agonist at ≥99% purity, HPLC-verified, with a Certificate of Analysis (COA) included with every order. Available in research-ready vials of 5mg, 10mg, 20mg, 30mg, and 40mg — this is the most complete Retatrutide peptide offering on the market today. Fast shipping to the USA, Canada, Germany, France, Australia, and most international destinations.

---

What Is Retatrutide? The Triple-Agonist Revolution Explained

Retatrutide — also known as LY3437943 or informally as “GLP-3” — is a synthetic investigational peptide developed by Eli Lilly. Unlike semaglutide (GLP-1 only) or tirzepatide (GLP-1 + GIP dual agonist), Retatrutide hits three receptor systems simultaneously. That’s the whole game right there.

GLP-1 Receptor Activation

Boosts insulin secretion in a glucose-dependent manner, slows gastric emptying, and powerfully suppresses appetite through central nervous system pathways. This is the foundation — and Retatrutide doesn’t stop here.

GIP Receptor Activation

Enhances the body’s insulin response to meals, improves lipid metabolism, and supports energy partitioning in adipose tissue. This broadens the metabolic impact well beyond what GLP-1 alone can achieve.

Glucagon Receptor (GCGR) Activation — The Game-Changer

This is what separates Retatrutide peptide from everything else on the market. GCGR stimulation actively boosts thermogenesis and energy expenditure — counteracting the metabolic slowdown that typically accompanies weight loss. You burn more. You stall less. No other incretin-based research compound does this.

The Synergistic Triple-Pathway Effect

The simultaneous activation of all three receptors creates a metabolic cascade that no single or dual agonist can replicate: reduced calorie intake + increased energy output + improved glycemic control, all at once. A 2024 cryo-electron microscopy study published in Cell Discovery confirmed the structural basis of Retatrutide’s triple agonism — showing it adopts a single continuous helix engaging all three receptor systems through conserved and receptor-specific molecular contacts. Precision at the atomic level.

“These weight loss results are the most reported so far in a medication tested for the treatment of type 2 diabetes, and we are hopeful these will be confirmed in longer and larger trials.” — Dr. Julio Rosenstock, MD, Director of Velocity Clinical Research at Medical City, presenting at the 83rd ADA Scientific Sessions, San Diego, 2023

---

Clinical Research Data: What the Numbers Actually Say

Let’s talk facts, not fluff. The clinical and peer-reviewed data on Retatrutide peptide has moved fast. Here’s a precise, honest breakdown of what’s confirmed:

Phase 3 TRIUMPH-4 (Eli Lilly, December 2025): At the 12mg dose, participants lost an average of 28.7% of body weight at 68 weeks — up to 71.2 lbs per person. At 9mg, average loss was 26.4%. The placebo group lost 2.1%. Additionally, 58.6% of participants at 12mg achieved ≥25% weight loss, and 39.4% achieved ≥30% weight loss. Seven additional Phase 3 trials are expected to report results in 2026. (Source: Eli Lilly press release, Dec 11, 2025)

Phase 2 Obesity Trial (NEJM, 2023): At 12mg over 48 weeks, 100% of participants achieved ≥5% weight loss, 93% achieved ≥10%, and 83% achieved ≥15%. Average weight reduction hit 24.2% — figures that stunned the metabolic research community when published.

Type 2 Diabetes Phase 2 (ADA Scientific Sessions, 2023): HbA1c dropped by 1.3%–2.0% versus no change with placebo and only 1.4% with dulaglutide. Average weight reduction for the 12mg group was 16.9% (17.2 kg / 37.8 lbs) over just 8 months.

Meta-Analysis — 878 Patients (PMC, 2025): Across three randomized controlled trials, Retatrutide significantly reduced body weight by a mean difference of 14.33%, BMI by 5.38 units, and waist circumference by 10.51 cm versus placebo. (Source: PMC12026077)

Cardiovascular Benefits (TRIUMPH-4): Systolic blood pressure dropped by 14.0 mmHg at the 12mg dose. Clinically meaningful improvements were observed in non-HDL cholesterol, high-sensitivity CRP, and triglycerides.

Osteoarthritis Pain Relief: Knee pain scores (WOMAC scale) improved by an average of 4.5 points vs. 2.4 points for placebo. A post-hoc analysis found that 14.1% of the 9mg group were completely pain-free at 68 weeks, vs. 4.2% on placebo.

Liver Fat & MASLD: A Phase 2a trial published in Nature Medicine demonstrated significant liver fat reduction and improved insulin sensitivity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), through a direct hepatic mechanism unique to Retatrutide.

---

Buy High Purity Retatrutide online

Whether you’re setting up a new metabolic research protocol, scaling an ongoing study, or stocking your lab’s peptide inventory — Swiss Chems Official has the right Retatrutide vial size for your needs. Every vial ships as lyophilized (freeze-dried) powder, the gold standard for peptide stability and shelf life.

Retatrutide 5mg

≥99% HPLC-verified · Lyophilized Powder · Ideal for pilot studies, initial assay development, and low-volume receptor binding experiments. For sale at Swiss Chems Official with fast worldwide shipping.

Retatrutide 10mg

≥99% HPLC-verified · Lyophilized Powder · Perfect for short-term studies, dose-escalation experiments, and comparative receptor assays. A versatile workhorse vial for most lab protocols. Buy yours today.

Retatrutide 20mg

≥99% HPLC-verified · Lyophilized Powder · Suited for mid-range assay work, extended protocols, and comparative metabolic studies requiring consistent supply across multiple sessions.

Retatrutide 30mg

≥99% HPLC-verified · Lyophilized Powder · Built for long-term metabolic research, multi-arm trial designs, and institutional orders where supply continuity is critical.

Retatrutide 40mg

≥99% HPLC-verified · Lyophilized Powder · The highest-volume option at Swiss Chems Official. Designed for high-output research programs, bulk experimental designs, and labs that need to buy powerful peptides at scale without compromising purity or consistency.

💡 Storage Tip: Lyophilized Retatrutide peptide powder stores at −20°C for up to 24 months without degradation. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28–30 days. Never freeze a reconstituted solution — it damages the peptide and kills your data.

---

Why Buy Retatrutide from Swiss Chems Official?

You could buy anywhere. So why does the source matter? Because purity determines your results. Period. Here’s what sets Swiss Chems official apart when you buy Retatrutide online:

≥99% Purity, Every Batch — Every vial of Retatrutide for sale at Swiss Chems official is independently HPLC-verified and mass spectrometry confirmed. Consistent, reliable material — not a mystery powder from an unverified supplier.

Certificate of Analysis (COA) Included — Every order ships with a third-party COA verifying identity, purity, and composition. Full transparency, zero guesswork.

Fast Worldwide Shipping — USA, Canada, Germany, France, Australia, and beyond. Orders dispatched rapidly with tracking provided on every shipment. Your timeline matters. We respect it.

Lyophilized for Maximum Stability — Shipped as freeze-dried powder, requiring no cold-chain dependency during transit. Stable at room temperature during shipping. Potency intact on arrival.

Endotoxin-Free, Cleanroom Processed — Manufactured under controlled cleanroom conditions, free from microbial contamination and endotoxins that would compromise your experimental data.

Five Vial Sizes for Every Research Stage — 5mg through 40mg. Scale your supply to exactly match your protocol, whether you’re running a quick pilot assay or a 48-week multi-arm study.

Trusted Internationally — Researchers and institutions across the USA, Canada, Germany, France, the UK, and Australia consistently choose Swiss Chems for high-quality research peptides because the quality holds, batch after batch.

---

Technical Specifications – Retatrutide (LY3437943)

Also Known As: LY3437943, GLP-3, Retatrutide acetate, Triple-G agonist, GGG triagonist, triple hormone receptor agonist

CAS Number: 2381089-83-2

Molecular Weight: ~4,811 Da

Half-Life: ~6 days (fatty-acid moiety enables once-weekly subcutaneous dosing in clinical study models)

Receptors Targeted: GLP-1R · GIPR · GCGR (glucagon receptor)

Form: Lyophilized (freeze-dried) powder, white to off-white

Solubility: ~5mg/mL in water; TFA salt form enhances aqueous solubility

Purity: ≥99% (HPLC + mass spectrometry verified)

Storage — Lyophilized: −20°C or below, protected from light and moisture; stable up to 24 months

Storage — Reconstituted: 2–8°C refrigerated; use within 28–30 days; do NOT freeze after reconstitution

Reconstitution Solvent: Bacteriostatic water (recommended); sterile 0.9% NaCl saline acceptable

Intended Use: In vitro research and laboratory experimentation only. Not for human or animal consumption.

---

How to Reconstitute Your Retatrutide Peptide – Step-by-Step

Reconstitution sounds complicated the first time. It isn’t. Follow this procedure and you’ll have a stable, sterile solution ready in under five minutes. Every step matters for data integrity and reproducibility.

Step 1 — Gather Your Supplies

You need: your Retatrutide vial, a vial of bacteriostatic water (BAC water), a sterile 1mL syringe, alcohol swabs, and clean nitrile gloves. Work in a clean, low-dust environment.

Step 2 — Disinfect Both Vials

Wipe the rubber stopper of both vials with a fresh alcohol swab. Allow to air dry for 30 seconds. Don’t skip this — contamination ruins results and wastes expensive reagent.

Step 3 — Draw and Inject BAC Water Slowly

Draw your required BAC water volume into the sterile syringe. For a 10mg vial, 2mL gives you a clean 5mg/mL concentration. Insert the needle and inject water slowly along the inner vial wall — not directly onto the powder. This prevents foaming and denaturation.

Step 4 — Dissolve Gently — Never Shake

Tilt and swirl the vial gently in circular motions. Never shake it. Give it 3–5 minutes. The solution should be clear, particle-free. If it stays cloudy after 10 minutes of gentle swirling — discard. It may be damaged or contaminated.

Step 5 — Label and Refrigerate Immediately

Label with date, concentration, and your initials. Store at 2–8°C. Use within 28–30 days. Document everything. Your research reproducibility depends on it.

---

Retatrutide vs. Other Metabolic Research Peptides

Researchers frequently ask how Retatrutide (LY3437943) stacks up against semaglutide and tirzepatide in a research context. Here’s an evidence-based breakdown:

vs. Semaglutide (GLP-1 single agonist): Semaglutide targets one receptor. Retatrutide targets three. Phase 2 weight loss data for Retatrutide (24% at 48 weeks) substantially exceeds typical semaglutide outcomes (~15% at 68 weeks). The GCGR component uniquely adds thermogenic energy expenditure — something semaglutide simply cannot replicate.

vs. Tirzepatide (GLP-1 + GIP dual agonist): Tirzepatide hits two receptors; Retatrutide hits three, with glucagon receptor activity as the key differentiator. Phase 3 Retatrutide data (28.7% at 68 weeks) exceeds comparable tirzepatide outcomes. The GCGR activation actively boosts energy expenditure rather than just reducing caloric intake.

Unique Liver and Lipid Mechanism: A 2024 mechanistic study found Retatrutide directly reduces ANGPTL3/8 protein complex secretion from liver cells — lowering triglycerides and LDL cholesterol through a direct hepatic pathway not observed with dual agonists.

Oncology Research Frontier: Emerging 2024–2025 studies indicate potential activity in metabolically driven cancer models, including triple-negative breast cancer resistance pathways — an entirely novel research direction for triple-agonist peptides.

---

FAQs About Retatrutide for Sale

1. What is Retatrutide and how does it work?

Retatrutide (LY3437943) is a synthetic investigational peptide that simultaneously activates three key metabolic hormone receptors: GLP-1R, GIPR, and GCGR. GLP-1 activation suppresses appetite and enhances insulin secretion; GIP activation improves the insulin response and lipid metabolism; glucagon receptor activation boosts thermogenesis and energy expenditure. The combined result is a synergistic triple-pathway metabolic effect that surpasses any single or dual-agonist approach in clinical research outcomes. Sold at Swiss Chems official as a research-grade peptide for laboratory use only — not for human consumption.

---

2. Where can I buy Retatrutide peptide online with fast shipping?

You can buy Retatrutide for sale directly at swisschemsofficial.com. Swiss Chems Official offers Retatrutide peptide in 5mg, 10mg, 20mg, 30mg, and 40mg vials with ≥99% HPLC-verified purity, COA included, and fast worldwide shipping to the USA, Canada, Germany, France, Australia, and most international destinations. Every batch is independently tested and dispatched rapidly after order confirmation.

---

3. What is the purity of Retatrutide sold at Swiss Chems?

Every vial of Retatrutide peptide at Swiss Chems Official is independently verified at ≥99% purity via HPLC and confirmed by mass spectrometry. A Certificate of Analysis (COA) accompanies every order with full documentation of identity, purity, and composition. Cleanroom manufacturing ensures each batch is endotoxin-free and free from microbial contamination.

---

4. How do I store Retatrutide peptide to preserve its potency?

Lyophilized Retatrutide powder stores at −20°C or below, protected from light and moisture — stable for up to 24 months. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 28–30 days. Never freeze a reconstituted solution — freeze-thaw cycles structurally damage the peptide and reduce potency. Always label vials with reconstitution date and concentration.

---

5. How do I reconstitute Retatrutide peptide?

Draw the required volume of bacteriostatic water into a sterile syringe — for a 10mg vial, 2mL gives a 5mg/mL concentration. Disinfect the vial stopper with an alcohol swab, then slowly inject BAC water down the inner vial wall (not directly onto the powder). Gently swirl — never shake — until fully dissolved into a clear solution (3–5 minutes). If the solution remains cloudy after 10 minutes, discard it. Refrigerate immediately and label with date and concentration.

---

6. What are the results from Retatrutide clinical trials?

In Eli Lilly’s Phase 3 TRIUMPH-4 trial (December 2025), participants at the 12mg dose lost an average of 28.7% of body weight at 68 weeks — up to 71.2 lbs per person. Phase 2 obesity trials showed average weight loss of 24.2% at 48 weeks at the 12mg dose, with 100% of participants achieving ≥5% weight loss, 93% achieving ≥10%, and 83% achieving ≥15%. In type 2 diabetes Phase 2 trials, HbA1c dropped by 1.3%–2.0% and the 12mg group lost an average of 16.9% body weight (17.2 kg) over 8 months. A 2025 meta-analysis across 878 patients confirmed a mean body weight reduction of 14.33% and BMI reduction of 5.38 units versus placebo.

---

7. Is Retatrutide FDA-approved?

No. Retatrutide is not yet FDA-approved. It is currently in Phase 3 clinical trials by Eli Lilly, with FDA approval projected no earlier than 2027. Swiss Chems sells Retatrutide peptide for research use only — not for human consumption, medical treatment, or veterinary use — in compliance with applicable research-use-only regulations.

---

8. What is the difference between Retatrutide, semaglutide, and tirzepatide?

Semaglutide is a GLP-1 single agonist. Tirzepatide is a GLP-1 + GIP dual agonist. Retatrutide is a GLP-1 + GIP + Glucagon triple agonist. The defining differentiator is glucagon receptor (GCGR) activation — which uniquely boosts thermogenesis and energy expenditure, actively fighting the metabolic slowdown that accompanies caloric restriction. Published Phase 3 data shows Retatrutide achieving 28.7% average weight loss at 68 weeks — surpassing either semaglutide or tirzepatide in comparable timeframes, with additional liver fat reduction and cardiovascular benefits.

---

9. What vial sizes of Retatrutide are available, and which should I choose?

Swiss Chems Official offers Retatrutide for sale in five vial sizes: 5mg, 10mg, 20mg, 30mg, and 40mg. The 5mg suits pilot assays and initial experiments. The 10mg and 20mg work well for short-to-medium protocols. The 30mg and 40mg are built for long-term, multi-arm, or high-volume institutional programs. Researchers who buy Retatrutide in larger vials benefit from consistent batch-matched supply across extended study periods.

---

10. Does Retatrutide affect liver fat or cholesterol?

Yes — and the data is compelling. A Phase 2a trial published in Nature Medicine showed Retatrutide significantly reduced liver fat and improved insulin sensitivity in MASLD patients. TRIUMPH-4 data showed meaningful improvements in non-HDL cholesterol, triglycerides, and high-sensitivity CRP at the 12mg dose. A 2024 mechanistic study revealed Retatrutide directly reduces ANGPTL3/8 secretion from liver cells — a lipid-raising protein complex — providing a direct hepatic cholesterol-lowering mechanism independent of weight loss alone.

---

11. What solvent should I use to reconstitute Retatrutide, sterile water or bacteriostatic water?

Bacteriostatic water (BAC water) is strongly recommended. BAC water contains 0.9% benzyl alcohol, which inhibits bacterial growth and allows safe multi-dose use from a single vial for up to 28–30 days. Sterile water has no preservative, is intended for single use only, and carries significantly higher contamination risk in multi-dose protocols. For any research requiring repeated dosing from one vial, BAC water is the correct choice.

---

12. What are the common side effects observed in Retatrutide clinical research?

The most commonly reported adverse events in TRIUMPH-4 included nausea (38–43% at higher doses vs. ~11% with placebo), diarrhea (~34%), constipation (~21–25%), vomiting (~21%), decreased appetite (~18–19%), and dysesthesia (8.8–20.9% at 9–12mg). Most adverse events were mild-to-moderate and gastrointestinal in nature. Discontinuation rates due to adverse events ranged from 12.2% (9mg) to 18.2% (12mg) vs. 4.0% with placebo. Proper research oversight and step-wise protocol management are essential.

---

13. Does Retatrutide ship internationally?

Yes! Swiss Chems Official ships Retatrutide peptide to researchers across the USA, Canada, Germany, France, Australia, the UK, and most international destinations. All vials ship as lyophilized powder — stable at room temperature during transit — with tracking provided on every shipment. International buyers are responsible for local import compliance. Orders are processed and dispatched rapidly so your research timeline stays on track.

---

⚠️ Research Use Only Disclaimer: All Retatrutide peptide products sold by Swiss Chems (swisschemsofficial.com) are intended strictly for in vitro research and laboratory experimentation by qualified professionals. Not intended for human or animal consumption, diagnosis, treatment, or prevention of any disease. These products have not been evaluated or approved by the FDA, EMA, or Health Canada. By purchasing, buyers confirm compliance with all applicable laws and regulations in their jurisdiction.